Brief: Brickell Biotech Inc Says Received Letter From Nasdaq Notifying Company That It Had Regained Compliance
22/01/2021 13:38
Jan 22 (Reuters) - Brickell Biotech Inc BBI.O :
* BRICKELL BIOTECH INC - ON JAN 21, 2021, CO RECEIVED A
LETTER
FROM NASDAQ NOTIFYING COMPANY THAT IT HAD REGAINED COMPLIANCE
* BRICKELL BIOTECH INC - HAS REGAINED COMPLIANCE WITH RULE
AND
NASDAQ CONSIDERS MATTER CLOSED
Source text: [ID: https://bit.ly/2LU8Npf]
Further company coverage: BBI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fresh Tracks Therapeutics
See all newsBrief: Fresh Tracks Therapeutics Announces Second Adjournment Of Special Meeting Of Stockholders
Brief: Fresh Tracks Therapeutics Intends To Seek Judicial Dissolution If Liquidation And Approved By Stockholders
Brief: Fresh Tracks Therapeutics Q3 EPS USD 0.32
Brief: Fresh Tracks Therapeutics Inc On October 10 Received A Notice From Listing Qualifications Department Of Nasdaq
U.S. STOCKS ON THE MOVE-Gold miners, Goosehead Insurance, FedEx